An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer

• Status: Unknown status
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This observational, multicenter, prospective study will evaluate the use of bevacizumab in real clinical practice in chinese patients with metastatic colorectal cancer.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Peking University
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• histologically confirmed metastatic colorectal cancer patients Having initiated treatment with bevacizumab

Exclusion Criteria:

• non-metastatic colorectal cancer patients not recieved bevacizumab